Conditions: Mesothelioma; Mesothelioma, Malignant; Mesothelioma; Pleura; Mesotheliomas Pleural; Mesothelioma Peritoneum; Cholangiocarcinoma; Cholangiocarcinoma Recurrent; Ovarian Cancer; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic Interventions: Drug: TC-210 T Cells; Drug: fludarabine; Drug: cyclophosphamide; Biological: anti-PD1 Sponsor: TCR2 Therapeutics Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Stage II, III; Nasopharyngeal Squamous Cell Carcinoma; Induction Chemotheray; Concurrent Chemoradiotherapy; Reduce Treatment Intensity Interventions: Drug: Docetaxel; Drug: Cisplatin; Radiation: IMRT Sponsor: Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Tue Apr 09, 2019 18:00
Conditions: Granulosa Cell Ovarian Cancer; Low Grade Serous Ovarian/ Primary Peritoneal Cancer; Endometrioid Endometrial Cancer Intervention: Drug: Onapristone ER Sponsors: Memorial Sloan Kettering Cancer Center; Context Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Esophageal Cancer; Non Small Cell Lung Cancer Intervention: Biological: Personalized mRNA Tumor Vaccine Sponsors: Stemirna Therapeutics; The First Affiliated Hospital of Zhengzhou University Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Endometrial Cancer; Overweight Intervention: Behavioral: Profile by Sanford weight management plan Sponsor: Sanford Health Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Hepatocellular Carcinoma; Cirrhosis; Liver Failure Interventions: Drug: Branch Chain Amino Acid; Other: maltodextrin Sponsors: Louisiana State University Health Sciences Center in New Orleans; University Medical Center-New Orleans Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Pain; Bone Metastases; Metastatic Breast Cancer Intervention: Sponsors: University of Copenhagen; The Novo Nordic Foundation Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Breast Cancer; Triple Negative Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: Nab-paclitaxel; Drug: Carboplatin; Drug: Herceptin Sponsor: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Condition: Hepatocellular Carcinoma Intervention: Biological: TBI 302 Sponsor: Therapure Biopharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Chemotherapeutic Toxicity; Breast Cancer Interventions: Dietary Supplement: Alpha-lipoic acid; Drug: Chemotherapy Sponsor: Damanhour University Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Condition: Metastatic Colorectal Cancer Intervention: Genetic: Blood sample Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Tue Apr 09, 2019 18:00
Conditions: Metastatic Pancreatic Cancer; Pancreatic Cancer; Pancreas Cancer; Pancreatic Adenocarcinoma Resectable; Pancreatic Ductal Adenocarcinoma; Pancreatic Metastasis Interventions: Drug: Ascorbic Acid; Drug: Paclitaxel protein-bound; Drug: Cisplatin; Drug: Gemcitabine Sponsors: Medical College of Wisconsin; Cancer Research UK; Stand Up To Cancer; Lustgarten Foundation; Destroy Pancreatic Cancer; Translational Genomics Research Institute; HonorHealth Research Institute...
Tue Apr 09, 2019 18:00
Condition: HER2 Positive Breast Carcinoma Intervention: Sponsor: Anhui Provincial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Condition: Advanced Malignancies Interventions: Drug: AZD7648; Drug: Pegylated liposomal doxorubicin (PLD); Drug: Olaparib Sponsors: AstraZeneca; Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Prostate Cancer; Head and Neck Cancer; Rectal Cancer Intervention: Other: Imaging Sponsor: Sunnybrook Health Sciences Centre Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Programmed Death-1 (PD-1) Antibody Combined With IMRT in Recurrent Nasopharyngeal Carcinoma Patients
Condition: Recurrent Nasopharyngeal Carcinoma Interventions: Drug: PD-1 blocking antibody; Radiation: IMRT Sponsor: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Tue Apr 09, 2019 18:00
Conditions: Von-Hippel Lindau; Kidney Disease, Chronic Interventions: Drug: Perflutren lipid microsphere; Drug: Sulfur hexafluoride lipid microspheres Sponsors: UNC Lineberger Comprehensive Cancer Center; Lantheus Medical Imaging; Vanderbilt University Recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Progressive Disease; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Refractory Fallopian Tube Carcinoma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal Carcinoma; Stage III Fallopian Tube Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Primary Peritoneal Cancer AJCC v8;...
Tue Apr 09, 2019 18:00
Conditions: Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma; Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma; Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma; Ann Arbor Stage IIIA Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma; Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma;...
Tue Apr 09, 2019 18:00
Condition: Colorectal Cancer Intervention: Behavioral: Inflatable colon educational module Sponsors: Dartmouth-Hitchcock Medical Center; National Cancer Institute (NCI) Active, not recruiting (Source: ClinicalTrials.gov)
Tue Apr 09, 2019 18:00
Conditions: Locally Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm; Progressive Disease Interventions: Drug: Capecitabine; Drug: Carboplatin; Biological: Durvalumab; Drug: Gemcitabine; Drug: Gemcitabine Hydrochloride; Drug: Nab-paclitaxel; Drug: Paclitaxel; Drug: Pegylated Liposomal Doxorubicin Hydrochloride Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search...
Tue Apr 09, 2019 18:00
Condition: Head and Neck Cancer Intervention: Other: NUTRI-HAB Sponsors: Odense University Hospital; REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care; University of Southern Denmark; University College Copenhagen; Odense Patient Data Explorative Network; Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Tue Apr 09, 2019 18:00
Conditions: Actinic Keratoses; Aging; Non-Melanoma Skin Cancer Intervention: Device: Fractionated Laser Resurfacing Sponsor: Jeffrey B. Travers, MD, PhD Recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Non-Squamous Non-Small Cell Lung Cancer Interventions: Biological: Nivolumab; Drug: Sitravatinib; Drug: Docetaxel Sponsors: Mirati Therapeutics Inc.; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Carcinoma, Squamous Cell Interventions: Drug: A317; Drug: VTX-2337 Sponsor: Celgene Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Nasopharyngeal Carcinoma Intervention: Drug: Anlotinib Sponsor: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Carcinoma Interventions: Biological: DCVAC/OvCa; Biological: DCVAC/OvCa placebo Sponsor: Sotio a.s. Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Non-Squamous Non-Small Cell Lung Cancer Interventions: Biological: Nivolumab; Drug: Sitravatinib; Drug: Docetaxel Sponsors: Mirati Therapeutics Inc.; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Mon Apr 08, 2019 18:00
Conditions: Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration Intervention: Drug: LOXO-292 Sponsors: Loxo Oncology, Inc.; Eli Lilly and Company Available (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Advanced or Metastatic CRC Intervention: Drug: utidelone injection Sponsors: Beijing Biostar Technologies, Ltd; Chengdu Biostar Pharmaceuticals, Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Colorectal Cancer Interventions: Behavioral: Community Colorectal Cancer Awareness, Research, Education& Screening (C-CARES) Materials; Behavioral: Contact Message; Behavioral: Personalized One on One Education; Diagnostic Test: Fecal Immunochemical Test (FIT) Sponsor: H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social...
Mon Apr 08, 2019 18:00
Conditions: Early-stage Breast Cancer; Hormone Receptor Positive Tumor Interventions: Drug: Letrozole; Drug: Letrozole and Prometrium; Drug: Tamoxifen and Prometrium Sponsor: St. Vincent's Hospital-Manhattan Recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Alcohol Drinking Intervention: Behavioral: High schools High on Life Sponsors: University of Southern Denmark; Danish Cancer Society Enrolling by invitation (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Solid Tumor Intervention: Drug: HS-201 Sponsor: Herbert Lyerly Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Mon Apr 08, 2019 18:00
Condition: Advanced Hepatocellular Carcinoma Interventions: Procedure: TACE; Drug: Lenvatinib Sponsor: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Condition: Breast Cancer Interventions: Drug: Endostar; Drug: Chemotherapy Sponsor: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Mon Apr 08, 2019 18:00
Conditions: Breast Cancer; Breast Neoplasms; Hormone Receptor Positive Tumor Intervention: Diagnostic Test: Multi-parameter tests Sponsors: Oslo University Hospital; KLINBEFORSK; Norwegian Cancer Society Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Nasopharyngeal Carcinoma Intervention: Drug: Tegafur-Gimeracil-Oteracil Sponsor: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Colorectal Cancer Stage III Intervention: Biological: anti-PD-1 antibody-activated TILs Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Apr 05, 2019 18:00
Conditions: Colorectal Cancer; Cardiovascular Disease; Bleeding Intervention: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: EGFR-mutant Non-Small Cell Lung Cancer Interventions: Drug: famitinib po; Drug: HS-10296 po Sponsor: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Neoplasm, Oral; Osteoradionecrosis of Jaw; Mandibular Diseases; Jaw Cancer; Jaw Diseases; Surgery Intervention: Procedure: Mandibular reconstruction with free tissue transfer. Sponsor: University of South Wales Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Peripheral T-cell Lymphoma-not Otherwise Specified; Mycosis Fungoides; Sezary Syndrome; ALK-negative Anaplastic Large Cell Lymphoma Interventions: Drug: rhIL-15; Biological: Avelumab Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Breast Cancer Interventions: Drug: Ribociclib; Other: Mono-chemotherapy; Other: Endocrine-Therapy Sponsors: Swiss Group for Clinical Cancer Research; The Belgian Society of Medical Oncology Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Apr 05, 2019 18:00
Condition: Metastatic Cancer Intervention: Behavioral: Exercise Therapy Sponsor: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Psychological Distress; Cancer Intervention: Other: Questionnaire Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Non-hodgkin Lymphoma; Hodgkin Lymphoma; Acquired Aplastic Anemia; Sickle Cell Disease Intervention: Other: Donor Search Prognosis Score Sponsors: Center for International Blood and Marrow Transplant Research; National Heart, Lung, and Blood Institute (NHLBI); National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials Network; National Marrow Donor Program; Medical College of Wisconsin...
Fri Apr 05, 2019 18:00
Condition: Medulloblastoma, Childhood Intervention: Drug: CX 4945 Sponsors: Pediatric Brain Tumor Consortium; St. Jude Children's Research Hospital; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Small Cell Lung Cancer Intervention: Drug: CM082 plus JS001 Sponsor: AnewPharma Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Renal Cell Carcinoma Metastatic Interventions: Drug: Abemaciclib; Drug: Sunitinib Sponsors: Milton S. Hershey Medical Center; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Thyroid Cancer Interventions: Other: Decision aid and SDM booster; Other: Deliberation training Sponsors: Radboud University; Dutch Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Fri Apr 05, 2019 18:00
Conditions: Bone Cancer; Bone Diseases Intervention: Device: custom made device Sponsors: Iva Hauptmannova; Adler Ortho Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Parent-Child Relations; Parenting; Communication Programs Intervention: Behavioral: Parental guidance Sponsors: Aurore Liénard; Centre de Psycho-Oncologie (CPO); Erasme University Hospital; Jules Bordet Institute; Université Libre de Bruxelles Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Oligorecurrent and Oligoprogressive Esophageal Squamous Cell Carcinoma Interventions: Other: Radiation, Surgery or Radiofrequency ablation; Drug: Chemotherapy Sponsor: Fudan University Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Liver Resection Intervention: Other: Watson on oncology surgery decision evaluation Sponsor: Zhujiang Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Depression Chronic; Advanced Cancer; Anxiety Interventions: Behavioral: Sophie CBT System; Behavioral: iHope CBT Sponsor: Boston Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Condition: Hyperglycemia Intervention: Drug: Insulin Sponsor: H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Apr 05, 2019 18:00
Conditions: Malignant Solid Tumor; Pain Interventions: Procedure: Acupuncture; Behavioral: Pain Counseling Sponsors: University of California, San Francisco; Patient-Centered Outcomes Research Institute Recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Conditions: Blasts 5 Percent or More of Bone Marrow Nucleated Cells; Recurrent Acute Myeloid Leukemia Interventions: Drug: Gemtuzumab Ozogamicin; Drug: Liposome-encapsulated Daunorubicin-Cytarabine Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Fri Apr 05, 2019 18:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου